Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations
Labcorp Holdings (NYSE: LH) reported Q2 CY2026 results in line with expectations. Revenue rose 5.8% year on year to $3.73 billion, and full-year revenue guidance was $14.77 billion at the midpoint. Non-GAAP adjusted EPS was $4.99, up 4.6% versus analysts’ consensus. The stock fell 4.7% to $292.77 after results.
How this was made
The 30-second read
Why it matters
The actionable signal is the combination of in-line revenue, an adjusted EPS beat, and near-consensus full-year revenue guidance, which can influence near-term positioning ahead of subsequent quarters.
Market read
Traders can reassess expectations for Labcorp’s earnings trajectory given the EPS beat and stable adjusted operating margin, while accounting for the immediate post-results selloff.
What to watch
The piece does not quantify cash flow, test volume trends, pricing vs mix, or guidance for EPS, which are often key for re-rating after earnings.
Background
Labcorp is a major healthcare diagnostics provider; this article summarizes its Q2 CY2026 results versus Wall Street expectations and reiterates full-year revenue guidance.
Ticker impact
Labcorp reported Q2 CY2026 revenue of $3.73B (+5.8% YoY) and adjusted EPS $4.99, beating consensus by 4.6%.
Near-term bias modestly positive, though the article notes the stock traded down 4.7% immediately after results, implying expectations were still high.
The text provides specific Q2 revenue, EPS beat vs consensus, and full-year revenue guidance midpoint, but lacks detail on margins, cash flow, or segment drivers that would explain the immediate post-print drop.
Market effects
Supports the diagnostics/lab testing demand narrative with mid-single-digit revenue growth and stable adjusted operating margin around 15.8%.
No explicit regional drivers mentioned.
No explicit global macro or cross-border regulatory catalysts mentioned.
Counterpoint
Despite the EPS beat, the article highlights revenue was in line and adjusted operating margin has been declining over five years, which can cap multiple expansion.
Key entities
- companyLabcorp Holdings
Reported Q2 CY2026 revenue and adjusted EPS, and provided full-year revenue guidance midpoint.
- executiveAdam Schechter
CEO/Chairman quoted on quarter performance and momentum.
